Scientists found that decreases in N6AMT1 correlated with the extent of DNA N6-methyladenosine (6mA) in clinical breast cancer (BC) tissues and predicted a worse survival of BC patients.
[Cell Death & Disease]
Sorry, but the selected Zotpress account can't be found.
